Shopping Cart
- Remove All
- Your shopping cart is currently empty
Bedaquiline fumarate (TMC207), a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections. It blocks the proton pump for ATP synthase of mycobacteria. It is the first member of a new class of drugs called diarylquinolines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $47 | In Stock | |
10 mg | $72 | In Stock | |
25 mg | $113 | In Stock | |
50 mg | $155 | In Stock | |
100 mg | $198 | In Stock | |
200 mg | $297 | In Stock | |
500 mg | $516 | In Stock | |
1 mL x 10 mM (in DMSO) | $71 | In Stock |
Description | Bedaquiline fumarate (TMC207), a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections. It blocks the proton pump for ATP synthase of mycobacteria. It is the first member of a new class of drugs called diarylquinolines. |
Alias | TMC-207, TMC207, TMC 207, R-403323, R403323, R 403323 |
Molecular Weight | 671.59 |
Formula | C36H35BrN2O6 |
Cas No. | 845533-86-0 |
Smiles | OC(=O)\C=C\C(O)=O.COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 27.5 mg/mL (40.95 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.